logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Ventricular Arrhythmia

    Medications for Ventricular Arrhythmia

    FiltersReset Filters
    7 results

    • flecainide acetate

      (flecainide acetate)
      Epic Pharma, LLC
      Usage: Flecainide Acetate Tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for documented life-threatening sustained ventricular tachycardia. Caution is advised due to proarrhythmic effects, and they should not be used post-myocardial infarction.

    • flecainide acetate

      (flecainide acetate)
      Bayshore Pharmaceuticals LLC
      Usage: Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for life-threatening documented ventricular arrhythmias, but should not be used post-myocardial infarction or for less severe arrhythmias. Consideration of risks is essential.

    • lidocaine hydrochloride and dextrose

      (LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE)
      B. Braun Medical Inc.
      Usage: Lidocaine hydrochloride is indicated for the acute management of ventricular arrhythmias during cardiac procedures and life-threatening ventricular arrhythmias associated with acute myocardial infarction.

    • mexiletine hydrochloride

      (mexiletine hydrochloride)
      Chartwell RX, LLC
      Usage: Mexiletine hydrochloride capsules are indicated for treating documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. Its use is not recommended for less severe arrhythmias or asymptomatic ventricular premature contractions. Initiation of treatment should occur in a hospital setting.

    • sotalol

      (Sotalol Hydrochloride)
      Bayshore Pharmaceuticals LLC
      Usage: Sotalol Hydrochloride Tablets are indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. The drug may not improve survival rates and is generally not recommended for less severe arrhythmias due to the risk of proarrhythmic effects, including Torsade de Pointes.

    • sotalol hydrochloride

      (Sotalol Hydrochloride)
      Epic Pharma, LLC
      Usage: Sotalol hydrochloride tablets (AF) are indicated for maintaining normal sinus rhythm in symptomatic atrial fibrillation/atrial flutter patients. They are also used to treat life-threatening ventricular arrhythmias. It is essential not to substitute Sotalol AF with regular sotalol due to significant differences in safety and dosing information.

    • sotylize

      (SOTALOL HYDROCHLORIDE)
      Azurity Pharmaceuticals, Inc.
      Usage: SOTYLIZE is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and for delaying the recurrence of highly symptomatic atrial fibrillation/atrial flutter in patients currently in sinus rhythm. It is not proven to enhance survival in these conditions.